TotalMarketCap

BridgeBio Pharma

BBIONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$14.476 B

$74.31 -4.60%

Close of 6 Nov 2026

As of 6 Nov 2026, BridgeBio Pharma (BBIO) has a market capitalization of $14.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$502.1M

#1888 by revenue

Earnings

—

Not reported

Shares outstanding

194,800,782

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #26Ascendis Pharma A/SASND$16.7B
  2. #27Jazz PharmaceuticalsJAZZ$14.6B
  3. #28BridgeBio PharmaBBIO$14.5B
  4. #29Dr Reddys LaboratoriesRDY$12.1B
  5. #30Elanco Animal HealthELAN$11.8B

What if BridgeBio Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$144,952.57

Per share 1,951× higher

Bitcoin $1.53T

$7,843.13

Per share 106× higher

Apple $5.02T

$25,748.27

Per share 346× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for BridgeBio Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.